Skip to content
Oriol Mirallas MD路 @DrMirallas 路 X路路 1 day agoScore70
Body 路 original

馃摚 Second Presidential Symposium
#ESMO26

馃憠馃徑 SAFFRON: Osimertinib + Savolitinib vs Platinum-Pemetrexed #EGFR #MET #
NSCLC

馃搶 PFS 7.6 vs 5.4m HR 0.55
馃搶 OS 17.8 vs 12.9m HR 0.68
鈽o笍 64% grade 3 or higher, OST frequent GI and hematologic

@OncoAlert @myESMO @ASCO @_SEOM @UTMDAnderson @NEJM @brunolarvol
馃憞馃徑馃憞馃徑

10 views 路 0 likes 路 0 reposts 路 0 replies

Source: Oriol Mirallas MD 路 x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website鈥檚 feedback page.